Investor List:

Top Medical Devices Series B Investors in Canada (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Robotics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series A), Investors in Hardware (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Health & Hospital Services (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in Hardware (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Geron Vanderfeesten, Managing Director at VDF Ventures
Geron Vanderfeesten
VDF Ventures·Managing Director
Sweet spot: $2.0M
Range: $500K - $15.0M
Investors in Middle East, Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Payments (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in AgTech (Seed), Investors in Payments (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in FinTech (Seed), Investors in Payments (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AgTech (Series A), Investors in Web3/Blockchain (Series A), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Medical Devices (Series A), Investors in AgTech (Series A), Investors in Cybersecurity (Series A), Investors in Payments (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in Payments (Series B), Investors in Medical Devices (Series B), Investors in AgTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Cybersecurity (Series B), Investors in Web3/Blockchain (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Medical Devices (Series B), Investors in AgTech (Series B), Investors in Payments (Series B), Investors in Cybersecurity (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Web3/Blockchain (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in Chemicals (Series A), Investors in Semiconductors (Series A), Investors in Material Science (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in Therapeutics (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in AI (Series A), Investors in Material Science (Series A), Investors in Semiconductors (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Material Science (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Chemicals (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Canada (Other Lists)
Photo of Soyoung Park, General Partner at 1004 Venture Partners
Soyoung Park
1004 Venture Partners·General Partner
Sweet spot: $500K
Range: $100K - $10.0M
Investors in South Korea, Investors in Japan, Investors in Europe, Investors in United Kingdom, Investors in Canada, Investors in United States
Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Generative Tech/AI (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Generative Tech/AI (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Generative Tech/AI (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Wellness & Fitness (Series B), Investors in Generative Tech/AI (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Robotics (Series B), Investors in Consumer Health (Series B), Investors in Canada (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Female Investors (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Diverse Investors (Other Lists)
Photo of Humayun H., Investor
Humayun H.
Investor
Sweet spot: $1M
Range: $100K - $10.0M
Investors in LatAm (Latin America), Investors in Mexico, Investors in Canada, Investors in United States, Investors in Asia, Investors in Europe
Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Consumer Internet (Seed), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Wellness & Fitness (Seed), Investors in Consumer Internet (Seed), Investors in Real Estate/PropTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Series A), Investors in Robotics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Digital Health (Series A), Investors in Consumer Internet (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Real Estate/PropTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Real Estate/PropTech (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Robotics (Series B), Investors in Canada (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in London (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Chris Angelatos, Associate at Esplanade HealthTech Ventures
Chris Angelatos
Sweet spot: $2.0M
Range: $500K - $7.5M
Investors in Israel, Investors in Europe, Investors in United States, Investors in Canada
Investors in Parenting/Families (Seed), Investors in Parenting/Families (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Parenting/Families (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Parenting/Families (Series A), Investors in Parenting/Families (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Parenting/Families (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Parenting/Families (Series B), Investors in Parenting/Families (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Consumer Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Parenting/Families (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Israel (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Get new data & insights delivered to your inbox